Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

More articles from Editorial

  • You have access
    Inconsistent radiotherapy effects between primary tumors and axillary lymph nodes
    Zhao Bi, Pengfei Qiu, Zhaopeng Zhang and Yongsheng Wang
    Cancer Biology & Medicine December 2022, 19 (12) 1617-1621; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0590
  • You have access
    Optimizing the cancer research landscape for the benefit of patients and society: A strategic perspective of the German Cancer Research Center (DKFZ) and its partnerships with university medical centers
    Michael Baumann
    Cancer Biology & Medicine November 2022, 19 (11) 1517-1522; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0586
  • You have access
    Insights into the transition of ductal carcinoma in situ to invasive ductal carcinoma: morphology, molecular portraits, and the tumor microenvironment
    Weiling Chen, Guimei Wang and Guojun Zhang
    Cancer Biology & Medicine October 2022, 19 (10) 1487-1495; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0440
  • You have access
    Role of the tumor microenvironment in shaping IDH-wildtype glioma plasticity, and potential therapeutic strategies
    Lingxiang Wu, Ruichao Chai, Zheng Zhao, Qianghu Wang and Tao Jiang
    Cancer Biology & Medicine October 2022, 19 (10) 1423-1427; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0363
  • You have access
    Reflections on the withdrawal of medical articles and the development of writing and publishing standards
    Lidong Wang and Zhihua Liu
    Cancer Biology & Medicine September 2022, 19 (9) 1283-1289; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0437
  • You have access
    Update on diffuse large B-cell lymphoma: highlights from the 2022 ASCO Annual Meeting
    Minghan Qiu, Shan Wu, Xinrui Chen and Huaqing Wang
    Cancer Biology & Medicine August 2022, 19 (8) 1117-1120; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0403
  • You have access
    Rosiglitazone disrupts pancreatic ductal adenocarcinoma progression by activating the tumor suppressor ESE3/EHF
    Hongquan Wang, Shuang Wu, Yan Wang and Bo Tang
    Cancer Biology & Medicine July 2022, 19 (7) 945-947; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0299
  • You have access
    Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification
    Jianbin Li and Zefei Jiang
    Cancer Biology & Medicine June 2022, 19 (6) 769-773; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0277
  • You have access
    PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer
    Han Liang
    Cancer Biology & Medicine May 2022, 19 (5) 565-568; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0244
  • You have access
    A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer
    Yuchen Guo, Yangyang Zhou and Wenxin Qin
    Cancer Biology & Medicine February 2022, 19 (2) 136-139; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0520

Pages

  • Next
  • 1
  • 2
  • 3
  • 4

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire